CIK: 0001737053
Total reported value
$38.1M
| # | Ticker | Issuer | Asset Subclass | Weight | Weight Change | Shares Change | 4Q Trend |
|---|---|---|---|---|---|---|---|
| 1 | ✓ | Apellis Pharmaceuticals, Inc | Stock-Other | 77.09% | +6.34% | — | |
| 2 | ✓ | Nabriva Therapeutics PLC | Stock-Other | 12.60% | — | — | |
| 3 | VRNA | Verona Pharma PLC - Adr | Stock-Other | 10.31% | +3.03% | — |